Finance & MarketsHigh Priority (8/10)

FDA declines to issue specific guidance on health programs' foreign drug imports

A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S. regulators say is a violation of import laws.

Key Points

  • A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S.
  • regulators say is a violation of import laws..

Full Details

A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S. regulators say is a violation of import laws.

Why It Matters

Finance & Markets story from CNBC. Click Enrich in admin for detailed analysis.

Sourcecnbc.com

Get stories like this delivered daily

AI-curated news, personalized to your interests. Zero noise.

Start 7-Day Free Trial →

More in Finance & Markets